Slovenian drug firm Krka's first-half sales rise 0.4 pct
LJUBLJANA, July 3
LJUBLJANA, July 3 (Reuters) - Slovenian pharmaceutical company Krka posted sales of 599.4 million euros ($817.6 million) in the first half of 2014, up 0.4 percent on the same period last year.
The biggest growth was in southeastern Europe where sales rose by 11 percent, it said in a statement on Thursday.
The company is due to report profit figures for the first six months of the year on July 24.
Shares in Krka, Slovenia's largest listed company, closed down 1.72 percent at 68.5 euros on Thursday, while the blue-chip SBI index lost 0.65 percent.
($1 = 0.7331 Euros) (Reporting By Marja Novak; Editing by Pravin Char)
- U.S., Arab partners launch first strikes in Syria
- Qatar adamant it will host 2022 World Cup despite doubts
- Argentina's Fernandez to meet billionaire investor Soros in New York
- Louisiana judge rules state's gay marriage ban unconstitutional
- China increasingly producing 'tools of torture' for export : Amnesty